Press "Enter" to skip to content

Statement on low-cost biosimilar and interchangeable protein products

FDA statement on low-cost biosimilar and interchangeable protein products

Original source: http://www.fda.gov/news-events/press-announcements/statement-low-cost-biosimilar-and-interchangeable-protein-products

Also Read:   Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new strategic framework to advance use of real-world evidence to support development of drugs and biologics